검색어 : 통합검색[Raymond Fred]
총 737건 중 737건 출력
, 74/74 페이지
-
731
- The relationship between a priori defined prognostic risk groups and and overall survival (OS) in men with metastatic hormone sensitive prostate cancer (mHSPC).
- Halabi, Susan; Guo, Siyuan S; Roy, Akash; Rydzewska, Larysa; Godolphin, Peter; Hussain, Maha H. A.; Tangen, Catherine; Thompson, Ian; Xie, Wanling; Carducci, Michael Anthony; Smith, Matthew Raymond; Morris, Michael J.; Gravis, Gwenaelle; Dearnaley, David P.; Verhagen, Paul; Goto, Takayuki; James, Nicholas D.; Parmar, Mahesh; Buyse, Marc E.; Sweeney, Christopher; Duke University Medical Center, Durham, NC; Duke University, Durham, NC; Duke University, Durham, NC; MRC Clinical Trials Unit at UCL, London, United Kingdom; MRC Clinical Trials Unit at UCL, London, United Kingdom; Northwestern University, Chicago, IL; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Christus Health, San Antonio, TX; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Institut Paoli-Calmettes, Marseille, France; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Erasmus Medical Center, Rotterdam, Netherlands; Deparment of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan; The Institute of Cancer Research, London, United Kingdom; Medica; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, 2023, pp.5073-5073)
-
732
- High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia
- Mabrey, Frances Linzee; Chien, Sylvia S; Martins, Timothy S; Annis, James; Sekizaki, Taylor S; Dai, Jin; Beckman, Robert A.; Loeb, Lawrence A.; Carson, Andrew; Patay, Bradley; Blau, Carl Anthony; Oehler, Vivian G.; Celik, Safiye S; Lee, Su-In; Monnat, Raymond J.; Abkowitz, Janis L.; Appelbaum, Frederick R.; Estey, Elihu H.; Becker, Pamela S; University of Washington, Seattle, WA; Institute for Stem Cell and Regenerative Medicine/Division of Hematology/Department of medicine, University of Washington, Seattle, WA; Institute for Stem Cell and Regenerative Medicine/Department of medicine, University of Washington, Seattle, WA; Institute for Stem Cell and Regenerative Medicine/Department of medicine, University of Washington, Seattle, WA; Institute for Stem Cell and Regenerative Medicine/ Department of medicine, University of Washington, Seattle, WA; Institute for Stem Cell and Regenerative Medicine/Division of Hematology/Department of medicine, University of Washington, Seattle, WA; Centocor, Inc., Malvern, PA; Pathology/Department of medicine, University of Washington, Seattle, WA; Invivoscribe Inc., San Diego, CA; Invivoscribe Inc., San Diego, CA; Institute for Stem Cell and Regenerative Medicine/Division of Hematology/Department of medicine, University of Washington, Seattle, WA; Fred Hutchinson Cancer Research; (Blood, v.132, 2018, pp.180-180)
-
733
- Polyploid circulating stromal cells in blood to identify invasive solid tumors and to prognosticate for highly aggressive cancer subtypes.
- Adams, Daniel L; Lin, Steven H.; Pass, Harvey I.; Edelman, Martin Joseph; Iwase, Toshiaki; Ueno, Naoto Tada; Bergan, Raymond C.; Tsai, Susan; Aldakkak, Mohammed; Aft, Rebecca; Watson, Mark; Kim, Amy K.; Chikamatsu, Kazuaki; Hayashi, Masanori; Loeb, David; Pinto, Navin; Ho, Thai Huu; Gaston, Sandra M.; Punnen, Sanoj; Marks, Jeffrey R; Creatv MicroTech, Inc., Monmouth Junction, NJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; NYU Langone Health, New York, NY; Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA; University of Hawaii Cancer Center, Honolulu, HI; University of Hawaii Cancer Center, Honolulu, HI; Fred & Pamela Buffett Cancer Center, Omaha, NE; The Ohio State University Wexner Medical Center, Columbus, OH; Department of Surgery, Medical College of Wisconsin, Milwaukee, WI; Washington University, St. Louis, MO; Washington University School of Medicine, Alliance for Clinical Trials in Oncology, St Louis, MO; Johns Hopkins School of Medicine, Baltimore, MD; Gunma University, Maebashi, Japan; University of Colorado at Denver - Anschutz Medical Campus, Aurora, CO; Albert Einstein College of Medicine, Bronx, NY; Seattle Children's Hospital, Seattle, WA; Mayo Clinic Arizona, Scottsdale, AZ; University of Miami Miller Sch; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.42, 2024, pp.3053-3053)
-
734
- Assessing intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).
- Halabi, Susan; Roy, Akash; Rydzewska, Larysa; Godolphin, Peter; Parmar, Mahesh K. B.; Hussain, Maha H. A.; Tangen, Catherine; Thompson, Ian; Xie, Wanling; Carducci, Michael Anthony; Smith, Matthew Raymond; Morris, Michael J.; Gravis, Gwenaelle; Dearnaley, David P.; Verhagen, Paul; Goto, Takayuki; James, Nicholas D.; Buyse, Marc E.; Tierney, Jayne F.; Sweeney, Christopher; Duke University Medical Center, Durham, NC; ; Duke University, Durham, NC; ; University College London, London, United Kingdom; ; MRC Clinical Trials Unit at UCL, London, United Kingdom; ; MRC Clinical Trials Unit at UCL, London, United Kingdom; ; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; ; Fred Hutchinson Cancer Research Center, Seattle, WA; ; Christus Health, San Antonio, TX; ; Dana-Farber Cancer Institute, Boston, MA; ; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; ; Massachusetts General Hospital Cancer Center, Boston, MA; ; Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; ; Institut Paoli-Calmettes Aix-Mareseille Université , Marseille, France; ; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom; ; Erasmus Medical Center, Rotterdam, Netherlands; ; Department of Urology, Graduate School of Medicine, Kyoto Univ; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.40, 2022, pp.5006-5006)
-
735
- Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families
- Jawaheer, Damini; Seldin, Michael F.; Amos, Christopher I.; Chen, Wei V.; Shigeta, Russell; Etzel, Carol; Damle, Aarti; Xiao, Xiangli; Chen, Dong; Lum, Raymond F.; Monteiro, Joanita; Kern, Marlene; Criswell, Lindsey A.; Albani, Salvatore; Nelson, J. Lee; Clegg, Daniel O.; Pope, Richard; Schroeder Jr., Harry W.; Bridges Jr., S. Louis; Pisetsky, David S.; Ward, Ryk; Kastner, Daniel L.; Wilder, Ronald L.; Pincus, Theodore; Callahan, Leigh F.; Flemming, Donald; Wener, Mark H.; Gregersen, Peter K.; Center for Genomics and Human Genetics, Manhasset, New York; University of California at Davis; University of Texas, Houston; University of Texas, Houston; University of California at Davis; University of Texas, Houston; Center for Genomics and Human Genetics, Manhasset, New York; Center for Genomics and Human Genetics, Manhasset, New York; University of California at Davis; University of California at San Francisco; Center for Genomics and Human Genetics, Manhasset, New York; Center for Genomics and Human Genetics, Manhasset, New York; University of California at San Francisco; University of California at San Diego; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Utah, Salt Lake City; Northwestern University Medical School, Chicago, Illinois; University of Alabama at Birmingham; University of Alabama at Birmingham; Durham Veterans Administration Hospital, and Duke University Medical Center, Durham, North Carolina; University of Oxford, Ox; (Arthritis and rheumatism, v.48, 2003, pp.906-916)
-
736
- Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease
- Young, William J.; Haessler, Jeffrey; Benjamins, Jan-Walter; Repetto, Linda; Yao, Jie; Isaacs, Aaron; Harper, Andrew R.; Ramirez, Julia; Garnier, Sophie; van Duijvenboden, Stefan; Baldassari, Antoine R.; Concas, Maria Pina; Duong, ThuyVy; Foco, Luisa; Isaksen, Jonas L.; Mei, Hao; Noordam, Raymond; Nursyifa, Casia; Richmond, Anne; Santolalla, Meddly L.; Sitlani, Colleen M.; Soroush, Negin; Thé riault, Sé bastien; Trompet, Stella; Aeschbacher, Stefanie; Ahmadizar, Fariba; Alonso, Alvaro; Brody, Jennifer A.; Campbell, Archie; Correa, Adolfo; Darbar, Dawood; De Luca, Antonio; Deleuze, Jean-Franç ois; Ellervik, Christina; Fuchsberger, Christian; Goel, Anuj; Grace, Christopher; Guo, Xiuqing; Hansen, Torben; Heckbert, Susan R.; Jackson, Rebecca D.; Kors, Jan A.; Lima-Costa, Maria Fernanda; Linneberg, Allan; Macfarlane, Peter W.; Morrison, Alanna C.; Navarro, Pau; Porteous, David J.; Pramstaller, Peter P.; Reiner, Alexander P.; William Harvey Research Institute, Clinical Pharmacology, Queen Mary University of London, London, UK; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA USA; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, the Netherlands; Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, Scotland; Institute for Translational Genomics and Population Sciences/The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA USA; Dept. of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Radcliffe Department of Medicine, University of Oxford, Division of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK; William Harvey Research Institute, Clinical Pharmacology, Queen Mary University of London, London, UK; Sorbonne Universite, INSERM, UMR-S1166, Research Unit on Cardiovascular Disorders, Metabolism and Nu; (Nature communications, v.14, 2023, pp.1411)
-
737
- Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
- Phillips, Kelly-Anne; Kotsopoulos, Joanne; Domchek, Susan M.; Terry, Mary Beth; Chamberlain, James A.; Bassett, Julie K.; Aeilts, Amber M.; Andrulis, Irene L.; Buys, Saundra S.; Cui, Wanda; Daly, Mary B.; Eisen, Andrea F.; Foulkes, William D.; Friedlander, Michael L.; Gronwald, Jacek; Hopper, John L.; John, Esther M.; Karlan, Beth Y.; Kim, Raymond H.; Kurian, Allison W.; Lubinski, Jan; Metcalfe, Kelly; Nathanson, Katherine L.; Singer, Christian F.; Southey, Melissa C.; Symecko, Heather; Tung, Nadine; Narod, Steven A.; Milne, Roger L.; Amor, David; Andrews, Lesley; Antill, Yoland; Balleine, Rosemary; Beesley, Jonathan; Bennett, Ian; Bogwitz, Michael; Bodek, Simon; Botes, Leon; Brennan, Meagan; Brown, Melissa; Buckley, Michael; Burke, Jo; Butow, Phyllis; Caldon, Liz; Campbell, Ian; Cao, Michelle; Chakrabarti, Anannya; Chauhan, Deepa; Chauhan, Manisha; Chenevix-Trench, Georgia; Christian, Alice; Cohen, Paul; Colley, Alison; Crook, Ashle; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, Ohio; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Clinical Genetics, Fox; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.43, 2025, pp.422-431)
QUICK MENU
